Bernhard Hubert GEIERSTANGER

Person

Solana Beach, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
CKIT antibody drug conjugates
- Patent number 11,833,215
- Issue date Dec 5, 2023
- Novartis AG
- Tinya Abrams
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CCR7 antibody drug conjugates
- Patent number 11,634,497
- Issue date Apr 25, 2023
- Novartis AG
- Steven Bender
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Specific sites for modifying antibodies to make immunoconjugates
- Patent number 11,596,695
- Issue date Mar 7, 2023
- Novartis AG
- Bernhard Hubert Geierstanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody drug conjugates for ablating hematopoietic stem cells
- Patent number 11,357,864
- Issue date Jun 14, 2022
- Novartis AG
- Ben Wen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of treating immune related disorders using antibody-cytokin...
- Patent number 11,136,366
- Issue date Oct 5, 2021
- Novartis AG
- Michael DiDonato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody conjugates comprising toll-like receptor agonist
- Patent number 10,973,826
- Issue date Apr 13, 2021
- Novartis AG
- Alex Cortez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CKIT antibody drug conjugates
- Patent number 10,786,578
- Issue date Sep 29, 2020
- Novartis AG
- Tinya Abrams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cytotoxic peptides and conjugates thereof
- Patent number 10,787,480
- Issue date Sep 29, 2020
- Novartis AG
- Bernhard Hubert Geierstanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of treating metabolic disorders with dual function fibrobla...
- Patent number 10,669,323
- Issue date Jun 2, 2020
- Novartis AG
- Brian R. Boettcher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cytotoxic peptides and conjugates thereof
- Patent number 10,392,421
- Issue date Aug 27, 2019
- Novartis AG
- Bernhard Hubert Geierstanger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cytotoxic peptides and conjugates thereof
- Patent number 10,280,139
- Issue date May 7, 2019
- Novartis AG
- Bernhard Hubert Geierstanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody cytokine engrafted compositions and methods of use for imm...
- Patent number 10,144,768
- Issue date Dec 4, 2018
- Novartis AG
- Michael DiDonato
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cytotoxic peptides and conjugates thereof
- Patent number 9,988,420
- Issue date Jun 5, 2018
- Novartis AG
- Bernhard Hubert Geierstanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Auristatin derivatives and conjugates thereof
- Patent number 9,884,817
- Issue date Feb 6, 2018
- Novartis AG
- Bernhard Hubert Geierstanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Biosynthetically generated pyrroline-carboxy-lysine and site specif...
- Patent number 9,624,520
- Issue date Apr 18, 2017
- Novartis AG
- Bernhard Geierstanger
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Site-specific labeling methods and molecules produced thereby
- Patent number 9,585,970
- Issue date Mar 7, 2017
- Novartis AG
- Bernhard Hubert Geierstanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fibroblast growth factor 21 mutations
- Patent number 9,023,791
- Issue date May 5, 2015
- Novartis AG
- Brian R. Boettcher
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Biosynthetically generated pyrroline-carboxy-lysine and site specif...
- Patent number 8,785,151
- Issue date Jul 22, 2014
- Bernhard Geierstanger
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTI-CCR7 ANTIBODY DRUG CONJUGATES
- Publication number 20240092918
- Publication date Mar 21, 2024
- Novartis AG
- Steven BENDER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES
- Publication number 20230270876
- Publication date Aug 31, 2023
- Novartis AG
- Bernhard Hubert Geierstanger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS
- Publication number 20220305134
- Publication date Sep 29, 2022
- Novartis AG
- Anthony Edward BOITANO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CYTOKINE ENGRAFTED COMPOSITIONS AND METHODS OF USE FOR IMM...
- Publication number 20220127321
- Publication date Apr 28, 2022
- NOVARTS AG
- Michael DiDonato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST
- Publication number 20210346387
- Publication date Nov 11, 2021
- Novartis AG
- Alex CORTEZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS
- Publication number 20210228731
- Publication date Jul 29, 2021
- Novartis AG
- Anthony Edward BOITANO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CKIT ANTIBODY DRUG CONJUGATES
- Publication number 20200405875
- Publication date Dec 31, 2020
- Novartis AG
- Tinya ABRAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES
- Publication number 20200338207
- Publication date Oct 29, 2020
- Novartis AG
- Bernhard Hubert Geierstanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCR7 ANTIBODY DRUG CONJUGATES
- Publication number 20200216548
- Publication date Jul 9, 2020
- Novartis AG
- Steven BENDER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST AND COMBI...
- Publication number 20200164084
- Publication date May 28, 2020
- Novartis AG
- Alex Cortez
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF
- Publication number 20190382441
- Publication date Dec 19, 2019
- Novartis AG
- Bernhard Hubert GEIERSTANGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS
- Publication number 20190321483
- Publication date Oct 24, 2019
- Novartis AG
- Ben WEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY-CYTOKINE ENGRAFTED COMPOSITIONS AND METHODS OF USE FOR IMM...
- Publication number 20190241636
- Publication date Aug 8, 2019
- NOVARTS AG
- Michael DiDonato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY DRUG CONJUGATES
- Publication number 20190194315
- Publication date Jun 27, 2019
- Novartis AG
- Tinya ABRAMS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF
- Publication number 20180244717
- Publication date Aug 30, 2018
- Novartis AG
- Bernhard Hubert GEIERSTANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CKIT ANTIBODY DRUG CONJUGATES
- Publication number 20180193475
- Publication date Jul 12, 2018
- Novartis AG
- Tinya ABRAMS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF
- Publication number 20180155281
- Publication date Jun 7, 2018
- Novartis AG
- Bernhard Hubert Geierstanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SITE-SPECIFIC LABELING METHODS AND MOLECULES PRODUCED THEREBY
- Publication number 20170218085
- Publication date Aug 3, 2017
- Novartis AG
- Bernhard Hubert GEIERSTANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DUAL FUNCTION PROTEINS FOR TREATING METABOLIC DISORDERS
- Publication number 20170166621
- Publication date Jun 15, 2017
- Novartis AG
- Brian R. BOETTCHER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AURISTATIN DERIVATIVES AND CONJUGATES THEREOF
- Publication number 20170121282
- Publication date May 4, 2017
- Novartis AG
- Bernhard Hubert Geierstanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST
- Publication number 20170121421
- Publication date May 4, 2017
- Novartis AG
- Alex CORTEZ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES
- Publication number 20170021033
- Publication date Jan 26, 2017
- Novartis AG
- Bernhard Hubert GEIERSTANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF
- Publication number 20160311853
- Publication date Oct 27, 2016
- Novartis AG
- Bernhard Hubert GEIERSTANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES
- Publication number 20160067351
- Publication date Mar 10, 2016
- Bernhard Hubert GEIERSTANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING FGF21-ASSOCIATED DISORDERS
- Publication number 20160051628
- Publication date Feb 25, 2016
- IRM LLC
- Brian R. BOETTCHER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SITE-SPECIFIC LABELING METHODS AND MOLECULES PRODUCED THEREBY
- Publication number 20150104468
- Publication date Apr 16, 2015
- IRM LLC
- Bernhard Hubert Geierstanger
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIF...
- Publication number 20140302553
- Publication date Oct 9, 2014
- IRM LLC
- Bernhard GEIERSTANGER
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Site-Specific Labeling Methods and Molecules Produced Thereby
- Publication number 20140065171
- Publication date Mar 6, 2014
- Bernhard Hubert GEIERSTANGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING FGF21-ASSOCIATED DISORDERS
- Publication number 20120129766
- Publication date May 24, 2012
- IRM LLC
- Brian R. BOETTCHER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIF...
- Publication number 20110262963
- Publication date Oct 27, 2011
- Bernhard Geierstanger
- C07 - ORGANIC CHEMISTRY

Bernhard Hubert GEIERSTANGER

Person

Patents Grantslast 30 patents

CKIT antibody drug conjugates

Anti-CCR7 antibody drug conjugates

Specific sites for modifying antibodies to make immunoconjugates

Antibody drug conjugates for ablating hematopoietic stem cells

Methods of treating immune related disorders using antibody-cytokin...

Antibody conjugates comprising toll-like receptor agonist

CKIT antibody drug conjugates

Cytotoxic peptides and conjugates thereof

Methods of treating metabolic disorders with dual function fibrobla...

Cytotoxic peptides and conjugates thereof

Cytotoxic peptides and conjugates thereof

Antibody cytokine engrafted compositions and methods of use for imm...

Cytotoxic peptides and conjugates thereof

Auristatin derivatives and conjugates thereof

Biosynthetically generated pyrroline-carboxy-lysine and site specif...

Site-specific labeling methods and molecules produced thereby

Fibroblast growth factor 21 mutations

Biosynthetically generated pyrroline-carboxy-lysine and site specif...

Patents Applicationslast 30 patents

ANTI-CCR7 ANTIBODY DRUG CONJUGATES

SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES

ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS

ANTIBODY CYTOKINE ENGRAFTED COMPOSITIONS AND METHODS OF USE FOR IMM...

ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST

ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS

CKIT ANTIBODY DRUG CONJUGATES

SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES

ANTI-CCR7 ANTIBODY DRUG CONJUGATES

ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST AND COMBI...

CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF

ANTIBODY DRUG CONJUGATES FOR ABLATING HEMATOPOIETIC STEM CELLS

ANTIBODY-CYTOKINE ENGRAFTED COMPOSITIONS AND METHODS OF USE FOR IMM...

ANTIBODY DRUG CONJUGATES

CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF

CKIT ANTIBODY DRUG CONJUGATES

CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF

SITE-SPECIFIC LABELING METHODS AND MOLECULES PRODUCED THEREBY

DUAL FUNCTION PROTEINS FOR TREATING METABOLIC DISORDERS

AURISTATIN DERIVATIVES AND CONJUGATES THEREOF

ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST

SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES

CYTOTOXIC PEPTIDES AND CONJUGATES THEREOF

SPECIFIC SITES FOR MODIFYING ANTIBODIES TO MAKE IMMUNOCONJUGATES

METHODS OF TREATING FGF21-ASSOCIATED DISORDERS

SITE-SPECIFIC LABELING METHODS AND MOLECULES PRODUCED THEREBY

BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIF...

Site-Specific Labeling Methods and Molecules Produced Thereby

METHODS OF TREATING FGF21-ASSOCIATED DISORDERS

BIOSYNTHETICALLY GENERATED PYRROLINE-CARBOXY-LYSINE AND SITE SPECIF...